Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
2,102,316
Value
$529.0M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABBV by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,102,316$529.0M0.3%+1,429,326+212.4%AddedHolders
Q1 2026672,990$146.4M0.1%+1,354+0.2%AddedHolders
Q4 2025671,636$153.5M0.1%−447,509−40.0%ReducedHolders
Q3 20251,119,145$259.1M0.2%−421,708−27.4%ReducedHolders
Q2 20251,540,853$286.0M0.3%+918,609+147.6%AddedHolders
Q1 2025622,244$130.4M0.2%+397,071+176.3%AddedHolders
Q4 2024225,173$40.0M<0.1%−401,734−64.1%ReducedHolders
Q3 2024626,907$123.8M0.2%−291,724−31.8%ReducedHolders
Q2 2024918,631$157.6M0.2%+178,932+24.2%AddedHolders
Q1 2024739,699$134.7M0.2%−326,055−30.6%ReducedHolders
Q4 20231,065,754$165.2M0.2%−54,054−4.8%ReducedHolders
Q3 20231,119,808$166.9M0.3%−543,840−32.7%ReducedHolders
Q2 20231,663,648$224.1M0.3%+1,532,290+1,166.5%AddedHolders
Q1 2023131,358$20.9M<0.1%+5,112+4.0%AddedHolders
Q4 2022126,246$20.4M<0.1%+11,663+10.2%AddedHolders
Q3 2022114,583$15.4M<0.1%+12,772+12.5%AddedHolders
Q2 2022101,811$15.6M<0.1%−174,802−63.2%ReducedHolders
Q1 2022276,613$44.8M0.1%+2,481+0.9%AddedHolders
Q4 2021274,132$37.1M<0.1%+33,958+14.1%AddedHolders
Q3 2021240,174$25.9M<0.1%+167,678+231.3%AddedHolders
Q2 202172,496$8.17M<0.1%+52,250+258.1%AddedHolders
Q1 202120,246$2.19M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.